Cross-Site Scripting Vulnerability in NEC Corporation UNIVERGE IX
CVE-2025-8153

5.1MEDIUM

Key Information:

Vendor

Nec Corporation

Status
Univerge Ix
Univerge Ix-r/ix-v
Vendor
CVE Published:
17 September 2025

What is CVE-2025-8153?

A cross-site scripting vulnerability exists in NEC Corporation's UNIVERGE IX, allowing attackers to inject arbitrary scripts into user browsers. This vulnerability is present from versions 9.5 through 10.11.6 and in the UNIVERGE IX-R/IX-V versions 1.3.16 and 1.3.21. Attackers can exploit this vulnerability to execute malicious scripts in the context of users' sessions, potentially leading to unauthorized actions and data theft. It is crucial for users of the affected products to apply the necessary security measures and updates to mitigate risks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

UNIVERGE IX from Ver.9.5 to Ver.10.7

UNIVERGE IX from Ver.10.8.21 to Ver.10.8.36

UNIVERGE IX from Ver.10.9.11 to Ver.10.9.24

References

https://jpn.nec.com/security-info/secinfo/nv25-005_en.html

CVSS V4

Score:
5.1
Severity:
MEDIUM
Confidentiality:
None
Integrity:
None
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Attack Required:
None
Privileges Required:
Undefined
User Interaction:
Unknown

Timeline

  • Vulnerability published

  • Vulnerability Reserved

Credit

RyotaK of GMO Flatt Security Inc.
JSON
.